Towards the Development of Tumor Necrosis Factor (TNF) Sensitizers:Making TNF Work Against Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|5|537-551

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.5, 2007-02, pp. : 537-551

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Dual Role of Tumor Necrosis Factor (TNF) in Cancer Biology

By  

Current Medicinal Chemistry, Vol. 17, Iss. 29, 2010-10 ,pp. : 3337-3352

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of tumour necrosis factor-alpha (TNF-)

By Tu G.   Cau Q-n.   Zhou F.   Isreal Y.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 23-25

Informa Healthcare

Access to resources Recommend Favorite

Family and case–control association study of the tumor necrosis factor-alpha (TNF-α) gene with schizophrenia and response to antipsychotic medication

By Zai Gwyneth   Müller Daniel   Volavka Jan   Czobor Pal   Lieberman Jeffrey   Meltzer Herbert   Kennedy James  

Psychopharmacology, Vol. 188, Iss. 2, 2006-10 ,pp. : 171-182

Springer Publishing Company

Access to resources Recommend Favorite

A Computational Study of the Oligosaccharide Binding Sites in the Lectin-Like Domain of Tumor Necrosis Factor and the TNF-derived TIP Peptide

By  

Current Pharmaceutical Design, Vol. 18, Iss. 27, 2012-09 ,pp. : 4236-4243

Bentham Science Publishers

Access to resources Recommend Favorite

Does Tumor Necrosis Factor- (TNF- ) Contribute to Myocardial Reperfusion Injury in Anesthetized Rats? - positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipram

By Jonsson J.   McVey M.   Perrone M.H.   Clark K.L.  

General Pharmacology, Vol. 32, Iss. 1, 1999-01 ,pp. : 41-45

Elsevier

Access to resources Recommend Favorite